DOXYCYCLINE IR-DR (doxycycline monohydrate)
TETRACYCLINES·SEVERE RECALCITRANT NODULAR ROSACEA
AVKARE
Indication
Severe recalcitrant nodular rosacea
Severe recalcitrant nodular rosacea is an advanced, treatment-resistant dermatologic presentation of chronic rosacea, most commonly affecting the central facial skin of adults. Read more about Severe recalcitrant nodular rosacea
13 drugs 11 manufacturers
Drugs that treat it
Common Severe recalcitrant nodular rosacea therapies.
DOXYCYCLINE IR-DR (doxycycline monohydrate)
TETRACYCLINES·SEVERE RECALCITRANT NODULAR ROSACEA
SOLCO HEALTHCAR
DOXYCYCLINE IR-DR (doxycycline monohydrate)
TETRACYCLINES·SEVERE RECALCITRANT NODULAR ROSACEA
AIPING PHARMACE
DOXYCYCLINE IR-DR (doxycycline monohydrate)
TETRACYCLINES·SEVERE RECALCITRANT NODULAR ROSACEA
MACLEODS PHARMA
Filter & compare in the drug finder →Opens the drug finder with Severe recalcitrant nodular rosacea preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSevere recalcitrant nodular rosacea is an advanced, treatment-resistant dermatologic presentation of chronic rosacea, most commonly affecting the central facial skin of adults.
It is characterized by persistent erythema and the formation of deep-seated, tender inflammatory nodules and plaques that fail to respond adequately to standard topical therapies or conventional oral antimicrobial regimens.
Pathophysiologically, it involves dysregulated innate immunity, neurovascular hyperactivity, and pronounced dermal infiltrate often exhibiting granulomatous inflammation centered around pilosebaceous units.
If left unmanaged, the severe ongoing inflammation can lead to progressive dermal fibrosis, significant facial lymphedema, and secondary tissue scarring.
- dermnetnz.org
Severe recalcitrant nodular rosacea is an advanced, treatment-resistant dermatologic presentation of chronic rosacea, most commonly affecting the central facial skin of adults Pathophysiologically, it involves dysregulated innate immunity, neurovascular hyperactivity, and pronounced dermal infiltrate often exhibiting granulomatous inflammation centered around pilosebaceous units
- ahdbonline.com
It is characterized by persistent erythema and the formation of deep-seated, tender inflammatory nodules and plaques that fail to respond adequately to standard topical therapies or conventional oral antimicrobial regimens
- pcds.org.uk
It is characterized by persistent erythema and the formation of deep-seated, tender inflammatory nodules and plaques that fail to respond adequately to standard topical therapies or conventional oral antimicrobial regimens Pathophysiologically, it involves dysregulated innate immunity, neurovascular hyperactivity, and pronounced dermal infiltrate often exhibiting granulomatous inflammation centered around pilosebaceous units
- ijdvl.com
It is characterized by persistent erythema and the formation of deep-seated, tender inflammatory nodules and plaques that fail to respond adequately to standard topical therapies or conventional oral antimicrobial regimens Pathophysiologically, it involves dysregulated innate immunity, neurovascular hyperactivity, and pronounced dermal infiltrate often exhibiting granulomatous inflammation centered around pilosebaceous units
Personalize your experience
Follow Severe recalcitrant nodular rosacea and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.